CoChat

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Effects of dietary n-3 fatty acids on hepatic and peripheral insulin sensitivity in insulin resistant humans

Open access

Abstract

OBJECTIVE: Dietary n-3 polyunsaturated fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), prevent insulin resistance and stimulate mitochondrial biogenesis in rodents, but the findings of translational studies in humans are thus far ambiguous. The aim of this study was to evaluate the influence of EPA and DHA on insulin sensitivity, insulin secretion, and muscle mitochondrial function in insulin-resistant, nondiabetic humans using a robust study design and gold-standard measurements. RESEARCH DESIGN AND METHODS: Thirty-one insulin-resistant adults received 3.9 g/day EPA+DHA or placebo for 6 months in a randomized double-blind study. Hyperinsulinemic-euglycemic clamp with somatostatin was used to assess hepatic and peripheral insulin sensitivity. Postprandial glucose disposal and insulin secretion were measured after a meal. Measurements were performed at baseline and after 6 months of treatment. Abdominal fat distribution was evaluated by MRI. Muscle oxidative capacity was measured in isolated mitochondria using high-resolution respirometry and noninvasively by magnetic resonance spectroscopy. RESULTS: Compared with placebo, EPA+DHA did not alter peripheral insulin sensitivity, postprandial glucose disposal, or insulin secretion. Hepatic insulin sensitivity, determined from the suppression of endogenous glucose production by insulin, exhibited a small but significant improvement with EPA+DHA compared with placebo. Muscle mitochondrial function was unchanged by EPA+DHA or placebo. CONCLUSIONS: This study demonstrates that dietary EPA+DHA does not improve peripheral glucose disposal, insulin secretion, or skeletal muscle mitochondrial function in insulin-resistant nondiabetic humans. There was a modest improvement in hepatic insulin sensitivity with EPA+DHA, but this was not associated with any improvements in clinically meaningful outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc14-3101

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 41 references

Cited by

See all 78

Metadata

Authors
Lalia, A. Z., Johnson, M. L., Jensen, M. D., Hames, K. C., Port, J. D., & Lanza, I. R.
Affiliations
Mayo Clinic (US)
Corresponding author
Lanza, Ian R.
Venue
Diabetes Care
Published
2015-04-07
Volume
38
Issue
7
Pages
1228-1237
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W2144635947
Cited by
73
References
41
Citations by year
2026: 1 · 2025: 7 · 2024: 6 · 2023: 2 · 2022: 6 · 2021: 6 · 2020: 13 · 2019: 3 · 2018: 7 · 2017: 10 · 2016: 10 · 2015: 2
FWCI
9.32
Type
journal article
Language
en
Open access
Locations
  • Diabetes Care (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (U24DK100469)
  • National Center for Advancing Translational Sciences (KL2 TR-000136)
  • National Center for Research Resources (DK50456)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
Keywords
omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, dietary supplementation, insulin resistance, hepatic insulin sensitivity, peripheral insulin sensitivity, insulin secretion, skeletal muscle mitochondrial function, muscle oxidative capacity, endogenous glucose production, abdominal fat distribution
MeSH terms
Insulin Secretion, Adult, Antimetabolites, Blood Glucose, Deoxyglucose, Docosahexaenoic Acids, Double-Blind Method, Humans, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mitochondria, Muscle, Eicosapentaenoic Acid, Glucose Clamp Technique, Postprandial Period, Insulin, Regular, Human, Meals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of dietary n-3 fatty acids on hepatic and peripheral insulin sensitivity in insulin resistant humans. https://app.cochat.ai/papers/10.2337/dc14-3101
The paper
Lalia, A. Z., Johnson, M. L., Jensen, M. D., Hames, K. C., Port, J. D., & Lanza, I. R. (2015). Effects of dietary n-3 fatty acids on hepatic and peripheral insulin sensitivity in insulin resistant humans. Diabetes Care. https://doi.org/10.2337/dc14-3101

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.